3 Followers on Owler
OverviewCompetitorsNews & Insights

BioSpecifics Competitors or Alternatives

BioSpecifics's top competitors include Petros, Fierce Pharma and Ascent Pharmaceuticals.

Unlock 20 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

BioSpecifics's company profile

CEO

- -
1 - 25
$0
$25M - 100M
  • $0
    $25M - 100M
  • 1 - 25
    $0
  • $25M - 100M
  • - -
  • 1 - 25
  • $0
  • $25M - 100M
View ProfileView
1
BioSpecifics's Competitor - Petros logo

Fady Boctor

President

90/100
20
$53.2M
$1.3M
  • $53.2M
    $1.3M
  • 20
    $53.2M
  • $1.3M
  • 90/100
  • 20
  • $53.2M
  • $1.3M
View ProfileView
2
BioSpecifics's Competitor - Fierce Pharma logo

CEO

- -
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • - -
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
3
BioSpecifics's Competitor - Ascent Pharmaceuticals logo

Sudhakar Vidiyala

President & CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
4
BioSpecifics's Competitor - MeiraGTx logo

Alexandria Forbes

President & CEO

90/100
300
$803.4M
$397.5M
  • $803.4M
    $397.5M
  • 300
    $803.4M
  • $397.5M
  • 90/100
  • 300
  • $803.4M
  • $397.5M
View ProfileView
5
BioSpecifics's Competitor - Innovus Pharma logo

Bassam Damaj

President & CEO

90/100
1 - 25
$14.6M
$5M - 25M
  • $14.6M
    $5M - 25M
  • 1 - 25
    $14.6M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $14.6M
  • $5M - 25M
View ProfileView
BioSpecifics' top 23 competitors are Petros, Fierce Pharma, Ascent Pharmaceuticals, Antares Pharma, MeiraGTx, Innovus Pharma, Voyager, Nymox, Auxilium Pharmaceuticals Inc, Sanofi Genzyme, BioMarin, Genentech, Amgen, Merix Pharmaceutical, Bristol-Myers Squibb, Sintact, Anchor Therapeutics, Johnson & Johnson, Flexion, Receptos, Alnylam, Roche and Teva. Together they have raised over 62.5B between their estimated 374.8K employees. BioSpecifics's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 13.5B. BioSpecifics has 7 employees and is ranked 22th among it's top 10 competitors. The top 10 competitors average 16,294.

BioSpecifics VS Petros

Petros is seen as one of BioSpecifics's top competitors. Petros was founded in 2020, and is headquartered in New York, New York. Like BioSpecifics, Petros also competes in the Pharmaceuticals industry. Petros generates $33.4M less revenue vs. BioSpecifics.

BioSpecifics VS Fierce Pharma

Fierce Pharma is a top competitor of BioSpecifics. Fierce Pharma was founded in 2008, and its headquarters is in New York, New York. Like BioSpecifics, Fierce Pharma also competes in the Pharmaceuticals field. Fierce Pharma has 23 more employees than BioSpecifics.

BioSpecifics VS Ascent Pharmaceuticals

Ascent Pharmaceuticals is BioSpecifics's #3 rival. Ascent Pharmaceuticals was founded in -, New York} in 2011. Like BioSpecifics, Ascent Pharmaceuticals also works within the Pharmaceuticals industry. Compared to BioSpecifics, Ascent Pharmaceuticals generates $ less revenue.

Looking for similar companies to BioSpecifics?

Similar Companies

Companies in Lynbrook with revenue in $25-100M range

See 23 companies 
Pharmaceuticals companies in New York

See 570 companies 
Companies in Lynbrook with employees in 1-25 range

See 35 companies 
Biotechnology companies in New York

See 662 companies 
Pharmaceuticals companies with revenue in $25-100M range

See 842 companies 
Biotechnology companies in New York Metropolitan Area

See 858 companies 
Biotechnology companies with revenue in $25-100M range

See 894 companies 
Pharmaceuticals companies in New York Metropolitan Area

See 1,039 companies 
Pharmaceuticals & Biotechnology companies in New York

See 1,130 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for BioSpecifics and BioSpecifics's Competitors

August 15, 2026Zolmax News
Elyxium Wealth LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 607.3% in the 2nd quarter, Holdings Channel.com reports. Th...
August 15, 2026Pharmaceutical Business Review
The combination is intended for patients who have previously received at least one line of therapy that included both a proteasome inhibitor and an imm...
August 15, 2026Seeking Alpha
August 16, 2026Zolmax News
TD Asset Management Inc increased its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 3.9% in the 2nd quarter, according to the company in its mo...
August 15, 2026Pharmaceutical Business Review
The combination is intended for patients who have previously received at least one line of therapy that included both a proteasome inhibitor and an imm...

Frequently Asked Questions about BioSpecifics

  1. Who are BioSpecifics's top competitors?

    BioSpecifics's top 3 competitors are Petros, Fierce Pharma, Ascent Pharmaceuticals.

  2. Who is similar to BioSpecifics?

    Petros is the most similar to BioSpecifics. Fierce Pharma and Ascent Pharmaceuticals are also similar to BioSpecifics.

  1. Are BioSpecifics and Petros competitors?

    Yes, Petros is one of BioSpecifics’s top competitors.